Hemoglobin screening in prospective blood donors: Comparison of different blood samples and different quantitative methods
Introduction
Hemoglobin determination before blood donation is obligatory in most countries, and a hemoglobin level below 125 g l−1 for females and 135 g l−1 for males is widely accepted as the donation cutoff. However, hemoglobin screening in donors is not standardized. The reference method for determination of hemoglobin is the cyanhemoglobin method provided by automatic hematology analyzers. However, this technique requires a venipuncture before blood donation, and is not suitable in mobile blood donation settings. The semiquantitative gravimetric copper sulfate method is very easy and inexpensive, but does not provide an acceptable degree of accuracy [1], [2], [3]. The spun microhematocrit method is often applied to retest donors who failed the copper sulfate screening [4], [5]. This technique is relatively time-consuming and impracticable. Therefore, many centers prefer portable photometer devices with special microcuvettes containing all necessary reagents in dry form. The precision of these devices seems to be satisfactory for venous samples, but not for capillary samples [2], [6], [7].
Here, we present the results of hemoglobin determination using different types of blood samples and different methods of testing.
Section snippets
Materials and methods
A total of 250 female and 250 male unselected prospective blood donors (age 18–67 years) were included in the study, which was approved by the Ethics Committee of the Charité—University Medicine Berlin, Germany. Informed consent was obtained from all volunteers.
In capillary blood samples, hemoglobin was measured by the acid methemoglobin method using a HemoCue B photometer (HemoCue, Großostheim, Germany), and a Biotest photometer (Biotest Medizintechnik GmbH, Alzenau, Germany). Venous
Results
The venous hemoglobin levels ranged from 94 to 176 g l−1. A total of 27% (68/250) of the females and 11% (28/250) of the males tested had unacceptable hemoglobin levels (<125 g l−1 for females and <135 g l−1 for males according to the German guidelines for blood donation).
As expected, the venous and fingerstick hemoglobin results correlated well (Pearson’s correlation coefficient r = 0.93 for HemoCue and r = 0.92 for Biotest). The fingerstick hemoglobin values tended to be higher than the venous
Discussion
These high rates of erroneous acceptance and deferral of blood donors due to inaccurate hemoglobin measurement underline the need to reduce errors in hemoglobin screening for prospective blood donors. In the present study, we compared the results of hemoglobin measurements obtained using different types of blood samples and different test systems. The mean deviation of fingerstick hemoglobin measurements obtained using two different portable photometers compared to venous hemoglobin
References (13)
Hemoglobin determination in blood donors
Transfusion Med Rev
(1995)- et al.
Evaluation of hemoglobin screening methods in prospective blood donors
Vox Sang
(1986) - et al.
Improved strategy for screening prospective blood donors for anaemia
Transfusion Med
(1994) - et al.
Statistical analysis of inappropriate results from current Hb screening methods for blood donors
Transfusion
(2003) - et al.
Hemoglobin screening in prospective blood donors: a comparison of methods
Transfusion
(1977) - et al.
A clinical evaluation of the HemoCue haemoglobinometer using capillary, venous and arterial samples
Anaesth Intens Care
(1992)
Cited by (56)
Evaluation of two methods to measure hemoglobin concentration among women with genetic hemoglobin disorders in Cambodia: A method-comparison study
2015, Clinica Chimica ActaCitation Excerpt :Issues relating to measurement error have been reported in the majority of studies; therefore, recommendations have been published to standardize blood collection and measurement practices [24–26]. There has been some investigation of the accuracy of HemoCue® to measure Hb in some clinical disease states, e.g. gastrointestinal bleeding [27] and as a screening tool for blood donations [28–30], however to our knowledge there has been no exploration of whether HemoCue® is as accurate as the gold standard hematology analyzer for measuring Hb in individuals with genetic Hb disorders. In Cambodia, genetic Hb disorders affect ~ 50% of the population, the most prevalent of which are Hb E variants and alpha-thalassemia [31–33].
Low hemoglobin deferral in blood donors
2014, Transfusion Medicine ReviewsCitation Excerpt :However, for many donors, complete recovery of iron stores and hemoglobin lost from whole blood donation is six months or longer [17]. Recovery time is dependent on pre-donation ferritin and reticulocyte hemoglobin content [17,24,57]. There have been several studies evaluating laboratory tests of red blood cell indices and iron status to assess their value to identify and manage donors at high risk for developing blood donation induced iron deficiency [21,23,24,26,57,58].
Comparison between two portable hemoglobinometers and a reference method to verify the reliability of screening in blood donors
2013, Transfusion and Apheresis ScienceCitation Excerpt :The hypothesis that the lack of agreement between these measures is caused by the type of sample (capillary blood) and not by the method of testing are based on the fact that when we tested venous blood in different devices (Table 4) Intraclass Correlation Coefficient (Table 5) was higher compared with capillary versus venous blood also in different devices. These findings corroborate the results found by Radtke et al. [13], in which the coefficient of variation was smaller and similar when they compared venous blood samples in HemoCue® and in hematological analyzer with capillary blood samples. In conclusion, although automated hematology analyzers are the reference method in the determination of Hb level, they are not suitable in mobile blood donation settings.
Assessment of the Key Performance Indicator Proposed by NABH in the Blood Centre of a Tertiary Health Care Hospital in Southern India
2023, Indian Journal of Hematology and Blood Transfusion